Betterlife Pharma Inc (BETR.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 01/31
(Values in thousands)
| 01-2025 | 01-2024 | 01-2023 | 01-2022 | 01-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8 | 37 | 8 | 174 | 155 |
| Receivables | 12 | 40 | 17 | 325 | 520 |
| Other current assets | 205 | 248 | 49 | 644 | 655 |
| TOTAL | $225 | $325 | $75 | $1,143 | $1,330 |
| Non-Current Assets | |||||
| PPE Net | 0 | N/A | 0 | 18 | 37 |
| TOTAL | $0 | $0 | $0 | $18 | $37 |
| Total Assets | $225 | $325 | $75 | $1,161 | $1,336 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 871 | N/A | 80 | 278 | 500 |
| Accounts payable and accrued liabilities | 4,495 | 4,977 | 5,436 | 3,341 | 4,503 |
| Other current liabilities | 313 | 4 | N/A | 0 | 182 |
| TOTAL | $7,538 | $6,827 | $7,147 | $4,143 | $5,847 |
| Non-Current Liabilities | |||||
| Long Term Debt | 49 | 328 | N/A | 35 | N/A |
| Other Non-Current Liabilities | -3,315 | -2,838 | -3,174 | 0 | 102 |
| TOTAL | $49 | $1,194 | $461 | $899 | $102 |
| Total Liabilities | $7,587 | $8,021 | $7,608 | $5,042 | $5,949 |
| Shareholders' Equity | |||||
| Common Shares | 79,965 | 78,460 | 76,572 | 75,385 | 63,671 |
| Retained earnings | -118,596 | -115,076 | -112,187 | -103,170 | -91,011 |
| Other shareholders' equity | 27,953 | 25,808 | 24,887 | 23,905 | 22,728 |
| TOTAL | $-10,678 | $-10,809 | $-10,728 | $-3,881 | $-4,612 |
| Total Liabilities And Equity | $-3,090 | $-2,788 | $-3,120 | $1,161 | $1,336 |